Ken Fisher's position in Veracyte is currently worth $17.4 Million. That's 0.01% of their equity portfolio (335th largest holding). The investor owns 1.20% of the outstanding Veracyte stock. The first Veracyte trade was made in Q1 2021. Since then Ken Fisher bought shares seven more times and sold shares on four occasions. The investor's estimated purchase price is $30.4 Million, resulting in a loss of 43%.